Phase 3 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 or older
- People who have been diagnosed with prostate cancer confirmed by a tissue sample (biopsy)
- People whose cancer falls within certain stages of spread, as classified by a standard medical staging system (confirm with trial site if unsure about stage)
- People who are planned to receive a full course of radiation therapy directed at the prostate or the area where the prostate was removed
- People who have a general health and activity level rated at a certain level (ECOG 0–2), meaning they are fully active to capable of some self-care, assessed within 90 days of joining the trial
- People who are able to sign a consent form approved by the trial's ethics board
- People who are able to complete all required tests before joining, within set timeframes
- People who are able to begin radiation treatment within 180 days of registering for the study
Who may not be able to join:
- People who have previously had radiation to the pelvic area at a dose greater than 5 Gy
- People for whom radiation to the pelvic lymph nodes is planned as part of their treatment
- People for whom internal radiation therapy (brachytherapy) to the prostate is planned
- People who currently have active rectal diverticulitis, Crohn's disease affecting the rectum, or active ulcerative colitis
- People who have previously had a hip replacement or a penile implant
- People with a significant medical, addiction-related, or mental health condition that, in the treating doctor's opinion, would affect their ability to consent, complete treatment, or attend follow-up appointments
- People who use a urinary catheter, either permanently or on and off
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Nathan Y. Yu, MD, Mayo Clinic
Phone: 855-776-0015
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of grade 3 or higher genitourinary (GU) and gastrointestinal (GI) adverse events (AEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.